Regencell Bioscience Holdings Limit... (RGC)

$29.6

-0.28 (-0.95%)
Rating:
Recommendation:
-
Symbol RGC
Price $29.6
Beta 0.000
Volume Avg. 0.00M
Market Cap 385.182M
Shares () -
52 Week Range 20.54-48.29
1y Target Est -
DCF Unlevered RGC DCF ->
DCF Levered RGC LDCF ->
ROE 1508.28% Strong Buy
ROA 623.23% Strong Buy
Operating Margin -
Debt / Equity 5.50% Neutral
P/E -
P/B 272.34 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest RGC news


Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.